Cargando…

Validation of the Oxford classification of IgA nephropathy for pediatric patients from China

BACKGROUND: The Oxford classification of IgA nephropathy (IgAN) provides a useful tool for prediction of renal prognosis. However, the application of this classification in children with IgAN needs validation in different patient populations. METHODS: A total of 218 children with IgAN from 7 renal c...

Descripción completa

Detalles Bibliográficos
Autores principales: Le, Weibo, Zeng, Cai-Hong, Liu, Zhangsuo, Liu, Dong, Yang, Qing, Lin, Rui-Xia, Xia, Zheng-Kun, Fan, Zhong-Min, Zhu, Guanghua, Wu, Ying, Xu, Hong, Zhai, Yihui, Ding, Ying, Yang, Xiaoqing, Liang, Shaoshan, Chen, Hao, Xu, Feng, Huang, Qian, Shen, Hongbing, Wang, Jianming, Fogo, Agnes B, Liu, Zhi-Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3519602/
https://www.ncbi.nlm.nih.gov/pubmed/23181565
http://dx.doi.org/10.1186/1471-2369-13-158
_version_ 1782252697128271872
author Le, Weibo
Zeng, Cai-Hong
Liu, Zhangsuo
Liu, Dong
Yang, Qing
Lin, Rui-Xia
Xia, Zheng-Kun
Fan, Zhong-Min
Zhu, Guanghua
Wu, Ying
Xu, Hong
Zhai, Yihui
Ding, Ying
Yang, Xiaoqing
Liang, Shaoshan
Chen, Hao
Xu, Feng
Huang, Qian
Shen, Hongbing
Wang, Jianming
Fogo, Agnes B
Liu, Zhi-Hong
author_facet Le, Weibo
Zeng, Cai-Hong
Liu, Zhangsuo
Liu, Dong
Yang, Qing
Lin, Rui-Xia
Xia, Zheng-Kun
Fan, Zhong-Min
Zhu, Guanghua
Wu, Ying
Xu, Hong
Zhai, Yihui
Ding, Ying
Yang, Xiaoqing
Liang, Shaoshan
Chen, Hao
Xu, Feng
Huang, Qian
Shen, Hongbing
Wang, Jianming
Fogo, Agnes B
Liu, Zhi-Hong
author_sort Le, Weibo
collection PubMed
description BACKGROUND: The Oxford classification of IgA nephropathy (IgAN) provides a useful tool for prediction of renal prognosis. However, the application of this classification in children with IgAN needs validation in different patient populations. METHODS: A total of 218 children with IgAN from 7 renal centers in China were enrolled. The inclusion criteria was similar to the original Oxford study. RESULTS: There were 98 patients (45%) with mesangial proliferation (M1), 51 patients (23%) with endocapillary proliferation (E1), 136 patients (62%) with segmental sclerosis/adhesion lesion (S1), 13 patients (6%) with moderate tubulointerstitial fibrosis (T1 26-50% of cortex scarred), and only 2 patients (1%) with severe tubulointerstitial fibrosis (T2, >50% of cortex scarred). During a median follow-up duration of 56 months, 24 children (12.4%) developed ESRD or 50% decline in renal function. In univariate COX analysis, we found that tubular atrophy/interstitial fibrosis (HR 4.3, 95%CI 1.8-10.5, P < 0.001) and segmental glomerulosclerosis (HR 9.2 1.2-68.6, P = 0.03) were significant predictors of renal outcome. However, mesangial hypercellularity, endocapillary proliferation, crescents, and necrosis were not associated with renal prognosis. In the multivariate COX regression model, none of these pathologic lesions were shown to be independent risk factors of unfavorable renal outcome except for tubular atrophy/interstitial fibrosis (HR 2.9, 95%CI 1.0-7.9 P = 0.04). CONCLUSIONS: We confirmed tubular atrophy/interstitial fibrosis was the only feature independently associated with renal outcomes in Chinese children with IgAN.
format Online
Article
Text
id pubmed-3519602
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35196022012-12-12 Validation of the Oxford classification of IgA nephropathy for pediatric patients from China Le, Weibo Zeng, Cai-Hong Liu, Zhangsuo Liu, Dong Yang, Qing Lin, Rui-Xia Xia, Zheng-Kun Fan, Zhong-Min Zhu, Guanghua Wu, Ying Xu, Hong Zhai, Yihui Ding, Ying Yang, Xiaoqing Liang, Shaoshan Chen, Hao Xu, Feng Huang, Qian Shen, Hongbing Wang, Jianming Fogo, Agnes B Liu, Zhi-Hong BMC Nephrol Research Article BACKGROUND: The Oxford classification of IgA nephropathy (IgAN) provides a useful tool for prediction of renal prognosis. However, the application of this classification in children with IgAN needs validation in different patient populations. METHODS: A total of 218 children with IgAN from 7 renal centers in China were enrolled. The inclusion criteria was similar to the original Oxford study. RESULTS: There were 98 patients (45%) with mesangial proliferation (M1), 51 patients (23%) with endocapillary proliferation (E1), 136 patients (62%) with segmental sclerosis/adhesion lesion (S1), 13 patients (6%) with moderate tubulointerstitial fibrosis (T1 26-50% of cortex scarred), and only 2 patients (1%) with severe tubulointerstitial fibrosis (T2, >50% of cortex scarred). During a median follow-up duration of 56 months, 24 children (12.4%) developed ESRD or 50% decline in renal function. In univariate COX analysis, we found that tubular atrophy/interstitial fibrosis (HR 4.3, 95%CI 1.8-10.5, P < 0.001) and segmental glomerulosclerosis (HR 9.2 1.2-68.6, P = 0.03) were significant predictors of renal outcome. However, mesangial hypercellularity, endocapillary proliferation, crescents, and necrosis were not associated with renal prognosis. In the multivariate COX regression model, none of these pathologic lesions were shown to be independent risk factors of unfavorable renal outcome except for tubular atrophy/interstitial fibrosis (HR 2.9, 95%CI 1.0-7.9 P = 0.04). CONCLUSIONS: We confirmed tubular atrophy/interstitial fibrosis was the only feature independently associated with renal outcomes in Chinese children with IgAN. BioMed Central 2012-11-27 /pmc/articles/PMC3519602/ /pubmed/23181565 http://dx.doi.org/10.1186/1471-2369-13-158 Text en Copyright ©2012 Le et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Le, Weibo
Zeng, Cai-Hong
Liu, Zhangsuo
Liu, Dong
Yang, Qing
Lin, Rui-Xia
Xia, Zheng-Kun
Fan, Zhong-Min
Zhu, Guanghua
Wu, Ying
Xu, Hong
Zhai, Yihui
Ding, Ying
Yang, Xiaoqing
Liang, Shaoshan
Chen, Hao
Xu, Feng
Huang, Qian
Shen, Hongbing
Wang, Jianming
Fogo, Agnes B
Liu, Zhi-Hong
Validation of the Oxford classification of IgA nephropathy for pediatric patients from China
title Validation of the Oxford classification of IgA nephropathy for pediatric patients from China
title_full Validation of the Oxford classification of IgA nephropathy for pediatric patients from China
title_fullStr Validation of the Oxford classification of IgA nephropathy for pediatric patients from China
title_full_unstemmed Validation of the Oxford classification of IgA nephropathy for pediatric patients from China
title_short Validation of the Oxford classification of IgA nephropathy for pediatric patients from China
title_sort validation of the oxford classification of iga nephropathy for pediatric patients from china
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3519602/
https://www.ncbi.nlm.nih.gov/pubmed/23181565
http://dx.doi.org/10.1186/1471-2369-13-158
work_keys_str_mv AT leweibo validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina
AT zengcaihong validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina
AT liuzhangsuo validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina
AT liudong validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina
AT yangqing validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina
AT linruixia validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina
AT xiazhengkun validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina
AT fanzhongmin validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina
AT zhuguanghua validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina
AT wuying validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina
AT xuhong validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina
AT zhaiyihui validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina
AT dingying validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina
AT yangxiaoqing validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina
AT liangshaoshan validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina
AT chenhao validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina
AT xufeng validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina
AT huangqian validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina
AT shenhongbing validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina
AT wangjianming validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina
AT fogoagnesb validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina
AT liuzhihong validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina